rethinkPeptides Search
Menu
Study breakdown

VIP Receptor Expression on Immune Cells Is Dynamically Regulated by Inflammatory Signals

In VitroPreliminary evidence
The takeaway

VPAC-1 receptor expression on primary mouse macrophages was regulated by both stimulatory (LPS, IFN-γ) and suppressive (IL-10, TGF-β) signals, explaining how the VIP anti-inflammatory system adapts to inflammatory context.

Key finding

VPAC-1 receptor on macrophages was upregulated by pro-inflammatory signals (LPS, IFN-γ) and downregulated by anti-inflammatory signals (IL-10, TGF-β)

What the researchers found

VPAC-1 receptor on macrophages was upregulated by pro-inflammatory signals (LPS, IFN-γ) and downregulated by anti-inflammatory signals (IL-10, TGF-β) — dynamic receptor regulation that adapts VIP anti-inflammatory sensitivity to the inflammatory microenvironment.

Why it matters

Relevant for neuropeptides, immune-function.

How the study worked

in-vitro study.

What this study cannot tell us

See abstract.

How to read the evidence

preliminary evidence.

When this study was published

Published in 2008.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.
  • Clinical translation to evaluate.

Common questions

What was studied?
VIP Receptor Expression on Immune Cells Is Dynamically Regulated by Inflammatory Signals
What was found?
VPAC-1 receptor expression on primary mouse macrophages was regulated by both stimulatory (LPS, IFN-γ) and suppressive (IL-10, TGF-β) signals, explaining how the VIP anti-inflammatory system adapts to inflammatory context.

Read the original research

Stimulatory and suppressive signal transduction regulates vasoactive intestinal peptide receptor-1 (VPAC-1) in primary mouse CD4 T cells.

Brain, behavior, and immunity, 22(7), 1024-1031

Citation

Vomhof-DeKrey, Emilie E; Dorsam, Glenn Paul. (2008). Stimulatory and suppressive signal transduction regulates vasoactive intestinal peptide receptor-1 (VPAC-1) in primary mouse CD4 T cells.. Brain, behavior, and immunity, 22(7), 1024-1031. https://doi.org/10.1016/j.bbi.2008.04.006